Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate
2. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate Monohydrochloride
3. Ak-taine
4. Alcaine
5. Benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester
6. Benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester, Monohydrochloride*benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester, Monohydrochloride
7. Chibro-kerakain
8. Kracaine
9. Kainair
10. Minims Proxymetacaine Hydrochloride
11. Ocu-caine
12. Ophthaine
13. Ophthetic
14. Parcaine
15. Proparacaine
16. Proparacaine Hcl
17. Proparakain-pos
18. Proxymetacaine
19. Proxymetacaine Hydrochloride
20. Proxymetacaine Monohydrochloride
21. Proxymethacaine
1. 5875-06-9
2. Proparacaine Hcl
3. Proxymetacaine Hydrochloride
4. Alcaine
5. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate Hydrochloride
6. Proparacaine, Hcl
7. Ophthaine
8. Ak-taine
9. Proparacaine (hydrochloride)
10. Kainair
11. Ophthetic
12. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate;hydrochloride
13. Nsc-759896
14. U96ol57goy
15. Dsstox_cid_28948
16. Dsstox_rid_83213
17. Dsstox_gsid_49022
18. Proparacaine Hydrochloride (usp)
19. Proparacaine Hydrochloride [usp]
20. Ophthain
21. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate Monohydrochloride
22. Benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester, Monohydrochloride
23. Smr000875264
24. Cas-5875-06-9
25. Ncgc00016991-03
26. Mfcd00083467
27. Keracaine
28. Chibro-heracaine
29. Ophthetic (tn)
30. Alcaine (tn)
31. Proparacainehydrochloride
32. Benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester, Hydrochloride
33. Unii-u96ol57goy
34. Schembl93880
35. Mls001333067
36. Mls001333068
37. Mls002154072
38. Chembl1200464
39. Dtxsid0049022
40. 2-diethylaminoethyl 3-amino-4-propoxybenzoate Hydrochloride
41. Hms1570p20
42. Pharmakon1600-01505688
43. Einecs 227-541-7
44. Tox21_113547
45. Nsc759896
46. S1828
47. Akos015844989
48. Tox21_113547_1
49. Ac-3399
50. Ccg-213513
51. Ks-5058
52. Nc00586
53. Nsc 759896
54. Proparacaine Hydrochloride [mi]
55. Benzoic Acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl Ester,monohydrochloride
56. Ncgc00016991-05
57. Hy-66012
58. Proparacaine Hydrochloride [vandf]
59. Proxymetacaine Hydrochloride, Proparacaine
60. Proparacaine Hydrochloride [usp-rs]
61. Proxymetacaine Hydrochloride [mart.]
62. P2156
63. Proxymetacaine Hydrochloride [who-dd]
64. Sw197338-3
65. Proparacaine Hydrochloride, Analytical Standard
66. C75748
67. D02098
68. Proparacaine Hydrochloride [green Book]
69. Proparacaine Hydrochloride [orange Book]
70. 875p069
71. A832009
72. Proparacaine Hydrochloride [usp Monograph]
73. 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate Hcl
74. Sr-05000001759-3
75. Q27290947
76. 2-diethylaminoethyl3-amino-4-propoxy-benzoatehydrochloride
77. Benzoic Acid,3-amino-4-propoxy-,2-(diethylamino)ethyl Ester
78. Beta-(diethylamino)ethyl 3-amino-4-n-propoxybenzoate Hydrochloride
79. 3-amino-4-propoxybenzoic Acid 2-(diethylamino)ethyl Ester Hydrochloride
80. 2-(diethylamino)ethyl 3-amino-4-propoxy-benzoate Hydrochloride;proparacaine Hcl
81. Proparacaine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 330.8 g/mol |
---|---|
Molecular Formula | C16H27ClN2O3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 10 |
Exact Mass | 330.1710204 g/mol |
Monoisotopic Mass | 330.1710204 g/mol |
Topological Polar Surface Area | 64.8 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 295 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Proparacaine hydrochloride |
Drug Label | ALCAINE (proparacaine hydrochloride ophthalmic solution, USP) 0.5% is a topical local anesthetic for ophthalmic use. The active ingredient is represented by the structural formula:Established name:Proparacaine Hydrochloride Chemical name:Benzoic ac... |
Active Ingredient | Proparacaine hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 0.5% |
Market Status | Prescription |
Company | Bausch And Lomb; Akorn |
2 of 2 | |
---|---|
Drug Name | Proparacaine hydrochloride |
Drug Label | ALCAINE (proparacaine hydrochloride ophthalmic solution, USP) 0.5% is a topical local anesthetic for ophthalmic use. The active ingredient is represented by the structural formula:Established name:Proparacaine Hydrochloride Chemical name:Benzoic ac... |
Active Ingredient | Proparacaine hydrochloride |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 0.5% |
Market Status | Prescription |
Company | Bausch And Lomb; Akorn |
Anesthetics, Local
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)
GDUFA
DMF Review : Complete
Rev. Date : 2018-08-29
Pay. Date : 2018-07-23
DMF Number : 2698
Submission : 1976-06-21
Status : Active
Type : II
Proparacaine hydrochloride USP
Date of Issue : 2019-09-12
Valid Till : 2022-09-11
Written Confirmation Number : WC-0174a1
Address of the Firm : Plot No, 6,7,8,20 &24, MIDC Industrial Area Badlapur Post Kulgaon, Dist Thane, 4...
Proparacaine Hydrochloride (USP)
Date of Issue : 2019-09-12
Valid Till : 2021-09-11
Written Confirmation Number : WC-0174
Address of the Firm : Plot No, 6,7,8,20 &24, MIDC Industrial Area Badlapur Post Kulgaon, Dist Thane, 4...
NDC Package Code : 73377-242
Start Marketing Date : 2023-07-24
End Marketing Date : 2029-04-30
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 76003-3500
Start Marketing Date : 2015-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17205-340
Start Marketing Date : 1996-06-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : BIOTECHNICA DWC LLC has carved a niche for itself in providing value added compliance, regulatory qualification, project management and GDP guidance services to pharma companies al...
About the Company : Green Stone Swiss Co ., ltd.is a high-tech enterprise of pharmaceuticals and health ingredients, and provide customized products/OEM/ODM. We signed technical cooperation agreements...
About the Company : As an internationally renowned outsourcing partner, we offer products and tailor-made service packages that are seamlessly embedded in the value chain of our customers. Our pharmac...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
RLD : Yes
TE Code :
Brand Name : OPHTHETIC
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 12583
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code : AT
Brand Name : ALCAINE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5%
Approval Date : 1982-01-01
Application Number : 80027
RX/OTC/DISCN : RX
RLD : No
TE Code : AT
RLD : No
TE Code : AT
Brand Name : PROPARACAINE HYDROCHLORIDE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5%
Approval Date : 1995-09-29
Application Number : 40074
RX/OTC/DISCN : RX
RLD : No
TE Code : AT
RLD : No
TE Code :
Brand Name : KAINAIR
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5%
Approval Date : 1983-06-07
Application Number : 88087
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Brand Name : OPHTHAINE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 8883
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code : AT
Brand Name : PROPARACAINE HYDROCHLORIDE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5%
Approval Date : 2000-03-16
Application Number : 40277
RX/OTC/DISCN : RX
RLD : No
TE Code : AT
RLD : No
TE Code : AT
Brand Name : PROPARACAINE HYDROCHLORIDE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5%
Approval Date : 2024-08-09
Application Number : 215816
RX/OTC/DISCN : RX
RLD : No
TE Code : AT
Brand Name : PROPARACAINE HYDROCHLORIDE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5%
Approval Date : 1982-01-01
Application Number : 84144
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Brand Name : PROPARACAINE HYDROCHLORIDE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5%
Approval Date : 1982-01-01
Application Number : 84151
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Brand Name : PARACAINE
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.5%
Approval Date : 1982-08-05
Application Number : 87681
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Canada
Brand Name : ALCAINE
Dosage Form : DROPS
Dosage Strength : 0.5%/W/V
Packaging : 15ML
Approval Date :
Application Number : 35076
Regulatory Info :
Registration Country : Canada
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Minims Proxymetacaine 0,5 %
Dosage Form : OPD
Dosage Strength : 6.14mg
Packaging : 0.5X20mg/0,5 ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : India
Brand Name : Aurocaine
Dosage Form : Ophthalmic Solution
Dosage Strength : 0.5%/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Ophthalmic Solution
Dosage Strength : 0.5%/5ML
Brand Name : Aurocaine
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Ophthalmic Solution
Dosage Strength : 0.5%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Ophthalmic Solution
Dosage Strength : 0.5%
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Proparacaine hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Proparacaine hydrochloride, including repackagers and relabelers. The FDA regulates Proparacaine hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Proparacaine hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Proparacaine hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Proparacaine hydrochloride supplier is an individual or a company that provides Proparacaine hydrochloride active pharmaceutical ingredient (API) or Proparacaine hydrochloride finished formulations upon request. The Proparacaine hydrochloride suppliers may include Proparacaine hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Proparacaine hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Proparacaine hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Proparacaine hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Proparacaine hydrochloride DMFs exist exist since differing nations have different regulations, such as Proparacaine hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Proparacaine hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Proparacaine hydrochloride USDMF includes data on Proparacaine hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Proparacaine hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Proparacaine hydrochloride suppliers with USDMF on PharmaCompass.
A Proparacaine hydrochloride written confirmation (Proparacaine hydrochloride WC) is an official document issued by a regulatory agency to a Proparacaine hydrochloride manufacturer, verifying that the manufacturing facility of a Proparacaine hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Proparacaine hydrochloride APIs or Proparacaine hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Proparacaine hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Proparacaine hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Proparacaine hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Proparacaine hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Proparacaine hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Proparacaine hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Proparacaine hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Proparacaine hydrochloride suppliers with NDC on PharmaCompass.
Proparacaine hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Proparacaine hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Proparacaine hydrochloride GMP manufacturer or Proparacaine hydrochloride GMP API supplier for your needs.
A Proparacaine hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Proparacaine hydrochloride's compliance with Proparacaine hydrochloride specifications and serves as a tool for batch-level quality control.
Proparacaine hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Proparacaine hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Proparacaine hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Proparacaine hydrochloride EP), Proparacaine hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Proparacaine hydrochloride USP).
LOOKING FOR A SUPPLIER?